Description
An antagonist of CRTH2/DP2 (IC50 = 42 nM in a radioligand binding assay); selective for binding to CRTH2/DP2 over DP1, thromboxane, and prostacyclin receptors (IC50s = 25.6, 62.6, and >100 μM, respectively); inhibits PGD2-induced shape change in human eosinophils (IC50 = 744 nM)
Formal name: 4,6-bis(dimethylamino)-2-[[4-[[4-(trifluoromethyl)benzoyl]amino]phenyl]methyl]-5-pyrimidineacetic acid
Synonyms: AP-761
Molecular weight: 501.5
CAS: 1093108-50-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Immunology & Inflammation||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway